ArticleIn vivo (Athens, Greece)

Modified Glasgow Prognostic Score 2 as a Prognostic Marker in Patients With Metastatic Urothelial Carcinoma.

Takashi Nagai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.